{"pub_date": "2016-09-20T04:00:00+0000", "subsection_name": null, "lead_paragraph": "Shares of Sarepta Therapeutics soared after the Food and Drug Administration approved its drug Exondys 51, a treatment for a type of muscular dystrophy.", "print_page": "4", "document_type": "article", "byline": {"person": [], "original": "By THE ASSOCIATED PRESS", "organization": "THE ASSOCIATED PRESS"}, "multimedia": [], "section_name": "Business Day", "headline": {"print_headline": "Wall St. Teeters as Investors Await Fed\u2019s Decision", "main": "Wall St. Teeters as Investors Await Fed\u2019s Decision on Rates"}, "source": "The New York Times", "blog": [], "word_count": "610", "web_url": "http://www.nytimes.com/2016/09/20/business/daily-stock-market-activity.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "Shares of Sarepta Therapeutics soared after the Food and Drug Administration approved its drug Exondys 51, a treatment for a type of muscular dystrophy....", "_id": "57dfef0895d0e021d798713f", "abstract": "Stocks finish mostly lower, as investors wait for word from central bank meetings in United States and Japan on interest rates.", "keywords": [{"rank": "1", "name": "subject", "value": "Stocks and Bonds", "is_major": "Y"}, {"rank": "2", "name": "subject", "value": "Nasdaq Composite Index", "is_major": "N"}, {"rank": "3", "name": "subject", "value": "Standard & Poor's 500-Stock Index", "is_major": "N"}, {"rank": "4", "name": "subject", "value": "Dow Jones Stock Average", "is_major": "N"}]}